Corrigendum to “Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay, the Two-Arm Rodent Somatosensory (TARS) task” [Brain Behav. Immun. 111 (2023) 177–185]
Clements, M.A., Kwilasz, A.J., Litwiler, S.T., Sents, Z., Woodall, B.J., Hayashida, K., Watkins, L.R.
Published in Brain, behavior, and immunity (01.10.2024)
Published in Brain, behavior, and immunity (01.10.2024)
Get full text
Journal Article
Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay, the Two-Arm Rodent Somatosensory (TARS) task
Clements, M.A., Kwilasz, A.J., Litwiler, S.T., Sents, Z., Woodall, B.J., Hayashida, K., Watkins, L.R.
Published in Brain, behavior, and immunity (01.07.2023)
Published in Brain, behavior, and immunity (01.07.2023)
Get full text
Journal Article
Corrigendum to "Intrathecal non-viral interleukin-10 gene therapy ameliorates neuropathic pain as measured by both classical static allodynia and a novel supra-spinally mediated pain assay, the Two-Arm Rodent Somatosensory (TARS) task" Brain Behav. Immun. 111 (2023) 177-185
Clements, M A, Kwilasz, A J, Litwiler, S T, Sents, Z, Woodall, B J, Hayashida, K, Watkins, L R
Published in Brain, behavior, and immunity (01.10.2024)
Published in Brain, behavior, and immunity (01.10.2024)
Get full text
Journal Article